Grace Therapeutics (NASDAQ:GRCE) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Grace Therapeutics (NASDAQ:GRCE) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.14, beating the consensus estimate of $-0.27 by $0.13 per share. Revenue came in at , meeting the estimate of .
Grace Therapeutics's stock moved following the earnings release. The stock currently trades at $3.50 with a market capitalization of $47.5M.
Current market data
NASDAQ · GRCE
$2.12
Down: -$0.01 · -0.47%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
sec_filing ·
sec_filing ·
earnings ·
sec_filing ·
